ALICIA VICK: Open Payments
NPI 1821762782 · BATON ROUGE, LA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$826 in 39 payments from 14 companies in 2025. Trend: 2023 $895 · 2024 $497 · 2025 $826
Food & beverage: $726Education: $100
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $192 |
| Janssen Biotech, Inc. | 4 | $157 |
| UROGEN PHARMA, INC. | 3 | $117 |
| Sumitomo Pharma America, Inc. | 4 | $81 |
| Endo USA, Inc. | 4 | $74 |
| Antares Pharma, Inc. | 2 | $39 |
| Kerecis Limited | 2 | $35 |
| Blue Earth Diagnostics | 1 | $22 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $20 |
| Astellas Pharma US Inc | 1 | $20 |
Products named: ERLEADA, BOTOX, GEMTESA, AVEED, XTANDI, XYOSTED, Kerecis SurgiClose, POSLUMA.
Industry payments across LA — which companies pay providers there.
